Archive · 17 Jun 2025
India Pharma Market Grows in May, Cardiac & Respiratory Therapies Lead
The Indian pharmaceutical market is doing well, growing by almost 7% in May.
This growth is fueled by medicines for heart issues, breathing problems, and diabetes.
Indian companies are growing, but multinational companies are growing a bit faster.
The market is dominated by Indian companies, holding most of the market share.
Experts predict the industry will continue to grow, by almost 8% next year, because of strong demand and new products.
India is a major supplier of affordable generic medicines globally.
India's pharma market grew 6.9% in May, driven by cardiac, respiratory, and anti-diabetes therapies.
Indian companies grew 6.6% while MNCs grew 8.4% year-over-year in May.
Acute therapy growth was 5% in May, the second consecutive month of muted growth.
Indian pharma companies hold 83% of the market share.
The Indian pharma industry is poised to grow 7.8% year-on-year in April 2025.
- Who
- The Indian Pharma Market and related companies.
- What
- India's pharma market growth.
- When
- May, for the latest data and April 2025 for future projections.
- Where
- India
- Why
- Driven by strong demand and new products.
Companies
Industry
Company Performance
Companies
JB Chem, Glenmark, and Ajanta recorded higher growth rates versus IPM.
Industry
The industry reported 7.6% YoY growth.
- IPM Growth (May)
- 6.9%
- Indian Companies Growth (May)
- 6.6%
- MNCs Growth (May)
- 8.4%
- Market Share (Indian Companies)
- 83%
- Projected Growth (April 2025)
- 7.8%